The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index.
Thyroid hormone in health and disease
Open accessAbstract
Thyroid disease is common, affecting around 2% of women and 0.2% of men in the UK. Our understanding of the effects of thyroid hormones under physiological circumstances, as well as in pathological conditions, has increased dramatically during the last two centuries and it has become clear that overt thyroid dysfunction is associated with significant morbidity and mortality. Both hypo-and hyperthyroidism and their treatments have been linked with increased risk from cardiovascular disease and the adverse effects of thyrotoxicosis in terms of osteoporosis risk are well established. Although the evidence suggests that successful treatment of overt thyroid dysfunction significantly improves overall survival, the issue of treating mild or subclinical hyper- and hypothyroidism remains controversial. Furthermore, the now well-established effects of thyroid hormones on neurodevelopment have sparked a whole new debate regarding the need to screen pregnant women for thyroid function abnormalities. This review describes the current evidence of the effects of thyroid hormone on the cardiovascular, skeletal and neurological systems, as well as the influence of thyroid diseases and their treatments on the development of malignancy. Furthermore we will describe some recent developments in our understanding of the relationship between thyroid status and health.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
HOSKINS, R. G. (1953) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-13-4-473 · Cited by 3,780
Risk Factors for Hip Fracture in White Women
Cummings, S. R., Nevitt, M. C., Browner, W. S., Stone, K., Fox, K. M., Ensrud, K. E., Cauley, J., Black, D., & Vogt, T. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199503233321202 · Cited by 3,595
THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
(1911) · Journal of the American Medical Association · doi:10.1001/jama.1911.04260070032017 · Cited by 3,361
The Colorado Thyroid Disease Prevalence Study
Canaris, G. J., Manowitz, N. R., Mayor, G., & Ridgway, E. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.526 · Cited by 2,824
THE SPECTRUM OF THYROID DISEASE IN A COMMUNITY: THE WHICKHAM SURVEY
TUNBRIDGE, W. M. G., EVERED, D. C., HALL, R., APPLETON, D., BREWIS, M., CLARK, F., EVANS, J. G., YOUNG, E., BIRD, T., & SMITH, P. A. (1977) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1977.tb01340.x · Cited by 2,674
Haddow, J. E., Palomaki, G. E., Allan, W. C., Williams, J. R., Knight, G. J., Gagnon, J., O'Heir, C. E., Mitchell, M. L., Hermos, R. J., Waisbren, S. E., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908193410801 · Cited by 2,558
The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey
Vanderpump, M. P. J., Tunbrldge, W. M. G., French, J. M., Appleton, D., Bates, D., Clark, F., Evans, J. G., Hasan, D. M., Rodgers, H., Tunbridge, F., et al. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01894.x · Cited by 2,432
Thyroid hormone and the cardiovascular system.
Klein, I., & Ojamaa, K. (2001) · New England Journal of Medicine · doi:10.1056/nejm200102153440707 · Cited by 2,300
Physiological and Molecular Basis of Thyroid Hormone Action
Yen, P. M. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.3.1097 · Cited by 2,011
Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., et al. (2004) · JAMA · doi:10.1001/jama.291.2.228 · Cited by 1,800
Self-citationHak, A. E., Pols, H. A. P., Visser, T. J., Drexhage, H. A., Hofman, A., & Witteman, J. C. M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-4-200002150-00004 · Cited by 1,336
Low Serum Thyrotropin Concentrations as a Risk Factor for Atrial Fibrillation in Older Persons
Sawin, C. T., Geller, A., Wolf, P. A., Belanger, A. J., Baker, E., Bacharach, P., Wilson, P., Benjamin, E. J., & D'Agostino, R. B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411103311901 · Cited by 1,259 · cited 5×
“Nonetheless, these data, together with the AF incidence data evident in the elderly Framingham population (Sawin et al. 1994), have lent support to the view that antithyroid treatment should be considered in those with persistent suppression of TSH and evidence for underlying thyroid disease (thyroid nodular disease o…”
BackgroundResultInfluentialThyroid Hormone Receptors: Multiple Forms, Multiple Possibilities*
LAZAR, M. A. (1993) · Endocrine Reviews · doi:10.1210/edrv-14-2-184 · Cited by 1,071
Pop, V. J., Kuijpens, J. L., van Baar, A. L., Verkerk, G., van Son, M. M., de Vijlder, J. J., Vulsma, T., Wiersinga, W. M., Drexhage, H. A., & Vader, H. L. (1999) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1999.00639.x · Cited by 1,009
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY, BIOLOGY, PHYSICS
(2004) · Archives of Ophthalmology · doi:10.1001/archopht.122.9.1382 · Cited by 877
Pop, V. J., Brouwers, E. P., Vader, H. L., Vulsma, T., Van Baar, A. L., & De Vijlder, J. J. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01822.x · Cited by 735
Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter
Friesema, E. C. H., Ganguly, S., Abdalla, A., Fox, J. E. M., Halestrap, A. P., & Visser, T. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300909200 · Cited by 725
Management of Simple Nodular Goiter: Current Status and Future Perspectives
Hegedüs, L., Bonnema, S. J., & Bennedbæk, F. N. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0016 · Cited by 710
Friesema, E. C., Grueters, A., Biebermann, H., Krude, H., von Moers, A., Reeser, M., Barrett, T. G., Mancilla, E. E., Svensson, J., Kester, M. H., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17226-7 · Cited by 709
Dumitrescu, A. M., Liao, X.-H., Best, T. B., Brockmann, K., & Refetoff, S. (2004) · The American Journal of Human Genetics · doi:10.1086/380999 · Cited by 706
Parle, J. V., Maisonneuve, P., Sheppard, M. C., Boyle, P., & Franklyn, J. A. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06067-6 · Cited by 669
Self-citationHypothyroidism and Atherosclerosis
Cappola, A. R., & Ladenson, P. W. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030398 · Cited by 640
Alexander, E. K., Marqusee, E., Lawrence, J., Jarolim, P., Fischer, G. A., & Larsen, P. R. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040079 · Cited by 633
Zoeller, R. T., & Rovet, J. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2004.01243.x · Cited by 605
Fade, J. V., Franklyn, J. A., Cross, K. W., Jones, S. C., & Sheppard, M. C. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01739.x · Cited by 567
Self-citationThe Journal of Thoracic and Cardiovascular Surgery
(2000) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(00)70283-2 · Cited by 562
Risk for fracture in women with low serum levels of thyroid-stimulating hormone
Bauer, D. C., Ettinger, B., Nevitt, M. C., Stone, K. L., & for the Study of Osteoporotic Fractures Research Group (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-7-200104030-00009 · Cited by 467
Thyroid Hormone Treatment after Coronary-Artery Bypass Surgery
Klemperer, J. D., Klein, I., Gomez, M., Helm, R. E., Ojamaa, K., Thomas, S. J., Isom, O. W., & Krieger, K. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512073332302 · Cited by 460
Maturation of the Secretion of Thyroid Hormone and Thyroid-Stimulating Hormone in the Fetus
Thorpe-Beeston, J. G., Nicolaides, K. H., Felton, C. V., Butler, J., & McGregor, A. M. (1991) · New England Journal of Medicine · doi:10.1056/nejm199102213240805 · Cited by 406
Effects on bone mass of long term treatment with thyroid hormones: a meta-analysis
Uzzan, B., Campos, J., Cucherat, M., Nony, P., Boissel, J. P., & Perret, G. Y. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.12.8954028 · Cited by 398
Hennemann, G., Docter, R., Friesema, E. C. H., de Jong, M., Krenning, E. P., & Visser, T. J. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.4.0435 · Cited by 394
Ontogenesis of Hypothalamic-Pituitary-Thyroid Function and Metabolism in Man, Sheep, and Rat
FISHER, D. A., DUSSAULT, J. H., SACK, J., & CHOPRA, I. J. (1977) · Proceedings of the 1976 Laurentian Hormone Conference · doi:10.1016/b978-0-12-571133-3.50010-6 · Cited by 380
Cancer Mortality Following Treatment for Adult Hyperthyroidism
Ron, E. (1998) · JAMA · doi:10.1001/jama.280.4.347 · Cited by 377
Prevalence of thyroid deficiency in pregnant women
Klein, R. Z., Haddow, J. E., Falx, J. D., Brown, R. S., Hermos, R. J., Pulkkinen, A., & Mitchell, M. L. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb03494.x · Cited by 372
Applications of a New Chemiluminometric Thyrotropin Assay to Subnormal Measurement*
SPENCER, C. A., LoPRESTI, J. S., PATEL, A., GUTTLER, R. B., EIGEN, A., SHEN, D., GRAY, D., & NICOLOFF, J. T. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-2-453 · Cited by 371
Biondi, B. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.12.4701 · Cited by 356
Clinical obstetrics and gynecology
Smith, C. V., Scott, J. C., & Rayburn, W. F. (1991) · McGraw-Hill, Health Professions Division, PreTest Series eBooks · Cited by 344
Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study
Kalmijn, S., Mehta, K. M., Pols, H. A. P., Hofman, A., Drexhage, H. A., & Breteler, M. M. B. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01146.x · Cited by 320
Subclinical hyperthyroidism as a risk factor for atrial fibrillation
Auer, J., Scheibner, P., Mische, T., Langsteger, W., Eber, O., & Eber, B. (2001) · American Heart Journal · doi:10.1067/mhj.2001.119370 · Cited by 314
Mortality after the Treatment of Hyperthyroidism with Radioactive Iodine
Franklyn, J. A., Maisonneuve, P., Sheppard, M. C., Betteridge, J., & Boyle, P. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803123381103 · Cited by 309
Self-citationCaraccio, N. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.4.1533 · Cited by 301
Vestergaard, P., & Mosekilde, L. (2002) · Thyroid · doi:10.1089/105072502760043503 · Cited by 289
Cloning and Characterization of Two Novel Thyroid Hormone Receptor β Isoforms
Williams, G. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.22.8329-8342.2000 · Cited by 284
A high-affinity subtype-selective agonist ligand for the thyroid hormone receptor
Chiellini, G., Apriletti, J. W., Yoshihara, H. A., Baxter, J. D., Ribeiro, R. C. J., & Scanlan, T. S. (1998) · Chemistry & Biology · doi:10.1016/s1074-5521(98)90168-5 · Cited by 278
Ross, D. S., Neer, R. M., Chester Ridgway, E., & Daniels, G. H. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90219-1 · Cited by 278
Cancer Risk After Iodine-131 Therapy for Hyperthyroidism
Holm, L.-E., Hall, P., Wiklund, K., Lundell, G., Berg, G., Bjelkengren, G., Cederquist, E., Ericsson, U.-B., Hallquist, A., Larsson, L.-G., et al. (1991) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/83.15.1072 · Cited by 268
Bettendorf, M., Schmidt, K. G., Grulich-Henn, J., Ulmer, H. E., & Heinrich, U. E. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02576-9 · Cited by 254
Long-term L-Thyroxine Therapy Is Associated With Decreased Hip Bone Density in Premenopausal Women
Paul, T. L. (1988) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1988.03720210027023 · Cited by 253
Franklyn, J. A., Maisonneuve, P., Sheppard, M., Betteridge, J., & Boyle, P. (1999) · The Lancet · doi:10.1016/s0140-6736(98)12295-x · Cited by 243
Self-citationRisk Factors for Cardiovascular Disease in Women with Subclinical Hypothyroidism
Luboshitzky, R., Aviv, A., Herer, P., & Lavie, L. (2002) · Thyroid · doi:10.1089/105072502760043512 · Cited by 241
Predictors of ankle and foot fractures in older women
Seeley, D. G., Kelsey, J., Jergas, M., & Nevitt, M. C. (1996) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650110920 · Cited by 221
Chernobyl-related ionising radiation exposure and cancer risk: an epidemiological review
Moysich, K. B., Menezes, R. J., & Michalek, A. M. (2002) · The Lancet Oncology · doi:10.1016/s1470-2045(02)00727-1 · Cited by 219
Long-term thyroxine treatment and bone mineral density
FRANKLYN, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)92423-d · Cited by 209
Self-citationVanderpump, M. P. J., Tunbridge, W. M. G., French, J. M., Appleton, D. R., Bates, D., Clark, F., Evans, J. G., Rodgers, H., Tunbridge, F. K. E., & Young, E. T. (1996) · PubMed · doi:10.1089/thy.1996.6.155 · Cited by 207
Maternal thyroid peroxidase antibodies during pregnancy: a marker of impaired child development?
Pop, V. J., de Vries, E., van Baar, A. L., Waelkens, J. J., de Rooy, H. A., Horsten, M., Donkers, M. M., Komproe, I. H., van Son, M. M., & Vader, H. L. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.12.8530599 · Cited by 206
KENDALL, E. C. (1915) · Journal of the American Medical Association · doi:10.1001/jama.1915.02570510018005 · Cited by 192
Fetal Thyroid Function: Diagnosis and Management of Fetal Thyroid Disorders
FISHER, D. A. (1997) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-199703000-00005 · Cited by 190
Stroke in thyrotoxicosis with atrial fibrillation.
Petersen, P., & Hansen, J. M. (1988) · Stroke · doi:10.1161/01.str.19.1.15 · Cited by 178
Management of atrial fibrillation in the post-thyrotoxic state
Nakazawa, H. K., Sakurai, K., Hamada, N., Momotani, N., & Ito, K. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90850-6 · Cited by 175
CORONARY-ARTERY DISEASE IN HYPOTHYROIDISM
Vanhaelst, L., Neve, P., Chailly, P., & Bastenie, P. A. (1967) · The Lancet · doi:10.1016/s0140-6736(67)92235-0 · Cited by 175
Graves' disease. Influence of age on clinical findings
Nordyke, R. A. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.148.3.626 · Cited by 174
(1993) · Europe PMC (PubMed Central) · Cited by 167
Grover, G. J., Egan, D. M., Sleph, P. G., Beehler, B. C., Chiellini, G., Nguyen, N.-H., Baxter, J. D., & Scanlan, T. S. (2004) · Endocrinology · doi:10.1210/en.2003-0973 · Cited by 163
Kempers, M. J. E., van Tijn, D. A., van Trotsenburg, A. S. P., de Vijlder, J. J. M., Wiedijk, B. M., & Vulsma, T. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030665 · Cited by 160
Occult thyrotoxicosis: A correctable cause of “idiopathic” atrial fibrillation
Forfar, J. C., Miller, H., & Toft, A. D. (1979) · The American Journal of Cardiology · doi:10.1016/0002-9149(79)90243-1 · Cited by 156
Myxedema and Coronary Artery Disease—A Comparative Autopsy Study
Steinberg, A. D. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-68-2-338 · Cited by 155
Hyperthyroidism, Thyroid Hormone Therapy, and Bone
Ross, D. S. (1994) · Thyroid · doi:10.1089/thy.1994.4.319 · Cited by 150
Long‐term follow‐up of treatment of thyrotoxicosis by three different methods
Franklyn, J. A., Daykin, J., Drolc, Z., Farmer, M. J., & Sheppard, M. C. (1991) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1991.tb01738.x · Cited by 139
Self-citationTreatment of Heart Disease Associated with Myxedema
KEATING, F. R., Parkin, T. W., Selby, J. B., & Dickinson, L. S. (1961) · Progress in Cardiovascular Diseases · doi:10.1016/s0033-0620(61)90004-4 · Cited by 139
Arterial Embolism in Thyrotoxicosis With Atrial Fibrillation
Bar-Sela, S. (1981) · Archives of Internal Medicine · doi:10.1001/archinte.1981.00340090087019 · Cited by 138
Biondi, B. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.78.5.1028 · Cited by 137
CORONARY-ARTERY DISEASE IN HYPOTHYROIDISM Observations in Preclinical Myx$oelig;dema
Bastenie, P. A. (1967) · The Lancet · doi:10.1016/s0140-6736(67)90562-4 · Cited by 135
Leese, G., Jung, R. T., Guthrie, C., Waugh, N. R., & Browning, M. C. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb01480.x · Cited by 131
Cancer mortality after iodine‐131 therapy for hyperthyroidism
Hall, P., Berg, G., Bjelkengren, G., Boice, J. D., Ericsson, U., Hallquist, A., Lidberg, M., Lundell, G., Tennvall, J., Wiklund, K., et al. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910500611 · Cited by 124
THE NATURE AND PROGNOSIS OF HEART DISEASE IN THYROTOXICOSIS
Sandler, G., & Wilson, G. M. (1959) · QJM · doi:10.1093/oxfordjournals.qjmed.a066847 · Cited by 124
Do Thyroid Function Tests Independently Predict Survival in the Critically Ill?
Maldonado, L., Murata, G. H., Hershman, J. M., & Braunstein, G. D. (1992) · Thyroid · doi:10.1089/thy.1992.2.119 · Cited by 123
Leukaemia incidence after iodine-131 exposure
Hall, P. N. (1992) · The Lancet · doi:10.1016/0140-6736(92)92421-b · Cited by 122
Cancer mortality in women with thyroid disease.
GOLDMAN, M. B., Monson, R. R., & Maloof, F. (1990) · PubMed · Cited by 120
Thyroid cancer risk after thyroid examination with131I: A population‐based cohort study in Sweden
Dickman, P. W., Holm, L., Lundell, G., Boice, J. D., & Hall, P. (2003) · International Journal of Cancer · doi:10.1002/ijc.11258 · Cited by 118
RADIOACTIVE IODINE THERAPY AND BREAST CANCER
GOLDMAN, M. B., Maloof, F., Monson, R. R., Aschengrau, A., Cooper, D. S., & Ridgway, E. C. (1988) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a114900 · Cited by 109
Borderline low thyroid function and thyroid autoimmunity. Risk factors for coronary heart disease?
Tièche, M., Lupi, G. A., Gutzwiller, F. S., Grob, P. J., Studer, H., & Bürgi, H. (1981) · Heart · doi:10.1136/hrt.46.2.202 · Cited by 109
Thyrotoxicosis, atrial fibrillation, and embolism, revisited
Presti, C. F., & Hart, R. G. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90642-x · Cited by 102
Dean, J. W., & Fowler, P. B. S. (1985) · BMJ · doi:10.1136/bmj.290.6481.1555 · Cited by 99
Mortality in patients treated for hyperthyroidism with iodine-131
Hall, P. N., Lundell, G. E. F., & Holm, L. (1993) · European Journal of Endocrinology · doi:10.1530/acta.0.1280230 · Cited by 97
How Useful Is Thyroid Function Testing in Patients With Recent-Onset Atrial Fibrillation?
Krahn, A. D. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.1996.00440180083010 · Cited by 94
Kibirige, M. S., Hutchison, S., Owen, C. J., & Delves, H. T. (2004) · Archives of Disease in Childhood Fetal & Neonatal · doi:10.1136/adc.2003.029306 · Cited by 94
Franklyn, J., Betteridge, J., Holder, R., Daykin, J., Lilley, J., & Sheppard, M. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb02572.x · Cited by 84 · cited 2×
“In a cross-sectional study comparing women treated for hyperthyroidism with radioiodine with age-matched controls, we found that femoral neck and lumbar spine BMD was significantly reduced in the post-menopausal group, although BMD was similar in patients and controls in the pre-menopausal group (Franklyn et al. 1994).”
ResultSelf-citationBeneficial Effects of a Novel Thyromimetic on Lipoprotein Metabolism
Taylor, A. H., Stephan, Z. F., Steele, R. E., & Wong, N. C. W. (1997) · Molecular Pharmacology · doi:10.1124/mol.52.3.542 · Cited by 84
Biological activities of thyroid hormone receptors
Munoz, A., & Bernal, J. (1997) · European Journal of Endocrinology · doi:10.1530/eje.0.1370433 · Cited by 81
Triiodothyronine repletion in infants during cardiopulmonary bypass for congenital heart disease
Portman, M. A., Fearneyhough, C., Ning, X., Duncan, B. W., Rosenthal, G. L., & Lupinetti, F. M. (2000) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2000.108900 · Cited by 79
Schulte, C., Reinhardt, W., Beelen, D. W., Mann, K., & Schaefer, U. W. (1998) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701502 · Cited by 71
Cancer Risk in Individuals with Benign Thyroid Disorders
Mellemgaard, A., From, G., Jørgensen, T., Johansen, C., Olsen, J. H., & Perrild, H. (1998) · Thyroid · doi:10.1089/thy.1998.8.751 · Cited by 64
Thyroid Cancer Rates and 131I Doses From Nevada Atmospheric Nuclear Bomb Tests
Gilbert, E. S., Tarone, R. E., Ron, E., & Bouville, A. C. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.21.1654 · Cited by 63
Girvent, M., Maestro, S., Hernández, R., Carajol, I., Monné, J., Sancho, J., Gubern, J. M., & Sitges‐Serra, A. (1998) · Surgery · doi:10.1067/msy.1998.87238 · Cited by 62
The management of atrial fibrillation
Gilligan, D. M., Ellenbogen, K. A., & Epstein, A. E. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(96)00194-5 · Cited by 59
Levothyroxine treatment and occurrence of fracture of the hip
Sheppard, M. C., Holder, R., & Franklyn, J. A. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.3.338 · Cited by 56
Self-citationEffect of replacement doses of thyroxine on bone mineral density
Hanna, F., Pettit, R. J., Ammari, Evans, W. D., Sandeman, D. D., & Lazarus, J. H. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.3871200.x · Cited by 53
Different dimerization activities of alpha and beta thyroid hormone receptor isoforms
Darling, D. S., Carter, R. L., Yen, P. M., Welborn, J., Chin, W. W., & Umeda, P. K. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82193-7 · Cited by 52
Vexiau, P., Perez‐Castiglioni, P., Socié, G., Devergié, A., Toubert, M. E., Aractingi, S., & Gluckman, É. (1993) · British Journal of Haematology · doi:10.1111/j.1365-2141.1993.tb03223.x · Cited by 52
MORTALITY IN WOMEN TREATED FOR HYPERTHYROIDISM
Hoffman, D. A., McConahey, W. M., Diamond, E. L., & Kurland, L. T. (1982) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a113296 · Cited by 50
Davies, P. H. O., Franklyn, J., Daykin, J., & Sheppard, M. C. (1992) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.74.5.1569166 · Cited by 39
Self-citationThyroxine replacement treatment and osteoporosis.
Franklyn, J., & Sheppard, M. (1990) · British medical journal · doi:10.1136/bmj.300.6726.693 · Cited by 32
Self-citationAdverse effects of subclinical hyperthyroidism
Fatourechi, V. (2001) · The Lancet · doi:10.1016/s0140-6736(01)06036-6 · Cited by 31
Selective thyromimetics: tissue-selective thyroid hormone analogs.
Ts, S., Yoshihara, H. A. I., Nh, N., & Chiellini, G. (2001) · PubMed · Cited by 21
Excess coronary artery bypass graft mortality among women with hypothyroidism
Zindrou, D., Taylor, K. M., & Bagger, J. P. (2002) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(02)04082-1 · Cited by 19
Gaiser, R. M. (2005) · Survey of Anesthesiology · doi:10.1097/01.sa.0000151207.30473.01 · Cited by 15
Low TSH Levels in Nursing Home Residents Not Taking Thyroid Hormone
Drinka, P. J., Amberson, J., Voeks, S. K., Schomisch, J., Schirz, P., & Christensen, D. (1996) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1996.tb01445.x · Cited by 12
Cited by
The Clinical Significance of Subclinical Thyroid Dysfunction
Biondi, B., & Cooper, D. S. (2008) · Endocrine Reviews · doi:10.1210/er.2006-0043 · Cited by 1,418
Ferdinandy, P., Schulz, R., & Baxter, G. F. (2007) · Pharmacological Reviews · doi:10.1124/pr.107.06002 · Cited by 744
Di(2-ethylhexyl) Phthalate Metabolites May Alter Thyroid Hormone Levels in Men
Meeker, J. D., Calafat, A. M., & Hauser, R. (2007) · Environmental Health Perspectives · doi:10.1289/ehp.9852 · Cited by 300
Vadiveloo, T., Donnan, P. T., Cochrane, L., & Leese, G. P. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2693 · Cited by 186
Haentjens, P., Van Meerhaeghe, A., Poppe, K., & Velkeniers, B. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0110 · Cited by 174
Metadata
- Authors
- Boelaert, K., & Franklyn, J. A.
- Venue
- Journal of Endocrinology
- Publisher
- Bioscientifica
- Published
- 2005-10
- Volume
- 187
- Issue
- 1
- Pages
- 1-15
- ISSN
- 0022-0795 (ISSN-L)
- 1479-6805
- OpenAlex
- W2126991953
- Cited by
- 282
- References
- 107
- FWCI
- 8.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.